Pulse Biosciences, Inc. Contract Liability (Deferred Revenue)
Pulse Biosciences, Inc. (PLSE) had Contract Liability (Deferred Revenue) of $4.00 thousand as of 2023-03-31, per its 10-Q filed 2023-05-11.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:ContractWithCustomerLiabilityCurrent · last filed 2023-05-11
- 2023-03-31: Contract with Customer, Liability, Current $4.00K.
- 2022-12-31: Contract with Customer, Liability, Current $0.00.
- 2022-09-30: Contract with Customer, Liability, Current $38.00K.
- 2022-06-30: Contract with Customer, Liability, Current $32.00K.
| Period end | Contract with Customer, Liability, Current |
|---|---|
| 2023-03-31 | $4.00K 10-Q · filed 2023-05-11 |
| 2022-12-31 | $0.00 10-Q · filed 2023-05-11 |
| 2022-09-30 | $38.00K 10-Q · filed 2022-11-10 |
| 2022-06-30 | $32.00K 10-Q · filed 2022-08-10 |
| 2022-03-31 | $16.00K 10-Q · filed 2022-05-11 |
| 2021-12-31 | $16.00K 10-K · filed 2023-03-31 |
| 2021-09-30 | $7.00K 10-Q · filed 2021-11-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| iRhythm Holdings, Inc. (IRTC) | United States | $3.651B | -281.06 |
| ICU MEDICAL INC/DE (ICUI) | United States | $4.153B | 18.85 |
| Heartflow, Inc. (HTFL) | United States | $4.225B | |
| AtriCure, Inc. (ATRC) | United States | $3.089B | |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| NovoCure Ltd (NVCR) | $1.886B | -11.87 |